Changchun High & New Technology Industries Group Inc Asset Resilience Ratio

Latest as of March 2026: 5.50%

Changchun High & New Technology Industries Group Inc asset resilience ratio. Changchun High & New Technology Industries Group Inc (000661) has an Asset Resilience Ratio of 5.50% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000661 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.69 Billion
≈ $247.46 Million USD Cash + Short-term Investments

Total Assets

CN¥30.77 Billion
≈ $4.50 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Changchun High & New Technology Industries Group Inc (1996–2025)

Asset resilience ratio of Changchun High & New Technology Industries Group Inc from 1996 to 2025. This chart shows how Changchun High & New Technology Industries Group Inc's Asset Resilience Ratio has changed over time. Read 000661 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Changchun High & New Technology Industries Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Changchun High & New Technology Industri.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.69 Billion 5.5%
Total Liquid Assets CN¥1.69 Billion 5.50%

Asset Resilience Insights

  • Limited Liquidity: Changchun High & New Technology Industries Group Inc maintains only 5.50% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Changchun High & New Technology Industries Group Inc Industry Peers by Asset Resilience Ratio

Compare Changchun High & New Technology Industries Group Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 29.37%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%
Shenzhen Chipscreen Biosciences Co
SHG:688321
Drug Manufacturers - Specialty & Generic 5.10%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
Drug Manufacturers - Specialty & Generic 0.00%
Luoxin Pharmaceuticals Group Stock Co Ltd
SHE:002793
Drug Manufacturers - Specialty & Generic 0.17%

Changchun High & New Technology Industries Group Inc Asset Resilience Ratio by Year (1996–2025)

Changchun High & New Technology Industries Group Inc asset resilience ratio by year from 1996 to 2025. The table below shows the annual Asset Resilience Ratio data for Changchun High & New Technology Industries Group Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 4.76% CN¥1.43 Billion
≈ $209.35 Million
CN¥30.08 Billion
≈ $4.40 Billion
+4.68pp
2024-12-31 0.08% CN¥24.96 Million
≈ $3.65 Million
CN¥31.05 Billion
≈ $4.54 Billion
+0.05pp
2023-12-31 0.03% CN¥9.96 Million
≈ $1.46 Million
CN¥30.74 Billion
≈ $4.50 Billion
+0.39pp
2022-12-31 -0.36% CN¥-93.39 Million
≈ $-13.67 Million
CN¥26.03 Billion
≈ $3.81 Billion
+0.22pp
2021-12-31 -0.57% CN¥-129.31 Million
≈ $-18.92 Million
CN¥22.52 Billion
≈ $3.29 Billion
-0.64pp
2020-12-31 0.06% CN¥10.28 Million
≈ $1.50 Million
CN¥16.91 Billion
≈ $2.47 Billion
-1.64pp
2019-12-31 1.70% CN¥215.86 Million
≈ $31.59 Million
CN¥12.72 Billion
≈ $1.86 Billion
-4.72pp
2018-12-31 6.41% CN¥605.00 Million
≈ $88.53 Million
CN¥9.43 Billion
≈ $1.38 Billion
-6.78pp
2017-12-31 13.19% CN¥970.00 Million
≈ $141.94 Million
CN¥7.35 Billion
≈ $1.08 Billion
-10.82pp
2016-12-31 24.02% CN¥1.49 Billion
≈ $218.03 Million
CN¥6.20 Billion
≈ $907.77 Million
+25.43pp
2015-12-31 -1.41% CN¥-53.95 Million
≈ $-7.89 Million
CN¥3.82 Billion
≈ $558.33 Million
-1.42pp
2014-12-31 0.01% CN¥179.55K
≈ $26.27K
CN¥3.15 Billion
≈ $460.71 Million
+4.31pp
2008-12-31 -4.30% CN¥-66.57 Million
≈ $-9.74 Million
CN¥1.55 Billion
≈ $226.45 Million
+0.75pp
2007-12-31 -5.05% CN¥-76.39 Million
≈ $-11.18 Million
CN¥1.51 Billion
≈ $221.22 Million
-5.07pp
2005-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.41 Billion
≈ $206.88 Million
0.00pp
2004-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.39 Billion
≈ $203.99 Million
+0.00pp
2003-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.55 Billion
≈ $226.98 Million
-0.01pp
2002-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.22 Billion
≈ $178.72 Million
+0.02pp
1998-12-31 0.01% CN¥87.65K
≈ $12.83K
CN¥1.30 Billion
≈ $190.46 Million
-0.54pp
1996-12-31 0.54% CN¥4.00 Million
≈ $584.70K
CN¥737.35 Million
≈ $107.90 Million
--
pp = percentage points

About Changchun High & New Technology Industries Group Inc

SHE:000661 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.40 Billion
CN¥30.09 Billion CNY
Market Cap Rank
#3770 Global
#497 in China
Share Price
CN¥73.77
Change (1 day)
-0.98%
52-Week Range
CN¥62.80 - CN¥105.06
All Time High
CN¥1174.87
About

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more